Statements
-
New United States government agreement for Evusheld
-
Statement on EU legal action
-
Update following MHRA and EMA decisions on AstraZeneca’s COVID-19 vaccine
-
Statement on COVID-19 vaccine supply at Anagni plant in Italy
-
Update following statement by NIAID on AZD1222 US Phase III trial data
-
Update on EU supply of COVID-19 Vaccine AstraZeneca
-
AstraZeneca’s COVID-19 vaccine: European Union supply commitment
-
Update on application for conditional marketing authorisation for the AstraZeneca COVID-19 vaccine to the European Medicines Agency